25 XP   0   0   10

Lionco Pharm Grp Co Ltd
Buy, Hold or Sell?

Let's analyse Lionco Pharm Grp Co Ltd together

PenkeI guess you are interested in Lionco Pharm Grp Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Lionco Pharm Grp Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Lionco Pharm Grp Co Ltd

I send you an email if I find something interesting about Lionco Pharm Grp Co Ltd.

Quick analysis of Lionco Pharm Grp Co Ltd (30 sec.)










What can you expect buying and holding a share of Lionco Pharm Grp Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.06
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥1.57
Expected worth in 1 year
¥-0.22
How sure are you?
88.9%

+ What do you gain per year?

Total Gains per Share
¥-1.35
Return On Investment
-31.5%

For what price can you sell your share?

Current Price per Share
¥4.29
Expected price per share
¥2.94 - ¥4.52
How sure are you?
50%

1. Valuation of Lionco Pharm Grp Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥4.29

Intrinsic Value Per Share

¥-5.60 - ¥-2.00

Total Value Per Share

¥-4.03 - ¥-0.43

2. Growth of Lionco Pharm Grp Co Ltd (5 min.)




Is Lionco Pharm Grp Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$156.6m$201.3m-$44.6m-28.5%

How much money is Lionco Pharm Grp Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$27m$9m-$36.1m-133.7%
Net Profit Margin-67.7%8.9%--

How much money comes from the company's main activities?

3. Financial Health of Lionco Pharm Grp Co Ltd (5 min.)




What can you expect buying and holding a share of Lionco Pharm Grp Co Ltd? (5 min.)

Welcome investor! Lionco Pharm Grp Co Ltd's management wants to use your money to grow the business. In return you get a share of Lionco Pharm Grp Co Ltd.

What can you expect buying and holding a share of Lionco Pharm Grp Co Ltd?

First you should know what it really means to hold a share of Lionco Pharm Grp Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Lionco Pharm Grp Co Ltd is ¥4.29. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Lionco Pharm Grp Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Lionco Pharm Grp Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥1.57. Based on the TTM, the Book Value Change Per Share is ¥-0.45 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.11 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Lionco Pharm Grp Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps-0.04-0.9%-0.04-0.9%0.010.3%0.020.4%0.020.5%
Usd Book Value Change Per Share-0.06-1.4%-0.06-1.4%0.00-0.1%-0.01-0.1%0.020.6%
Usd Dividend Per Share0.020.4%0.020.4%0.030.7%0.030.7%0.020.5%
Usd Total Gains Per Share-0.05-1.1%-0.05-1.1%0.030.6%0.020.5%0.051.1%
Usd Price Per Share0.79-0.79-1.38-1.15-1.94-
Price to Earnings Ratio-21.15--21.15-109.33-38.47-65.55-
Price-to-Total Gains Ratio-17.00--17.00-52.15-24.14-47.40-
Price to Book Ratio3.65-3.65-4.94-4.40-8.22-
Price-to-Total Gains Ratio-17.00--17.00-52.15-24.14-47.40-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.59202
Number of shares1689
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.03
Usd Book Value Change Per Share-0.06-0.01
Usd Total Gains Per Share-0.050.02
Gains per Quarter (1689 shares)-78.7137.07
Gains per Year (1689 shares)-314.84148.28
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1104-418-325191-42138
2207-837-640381-85286
3311-1255-955572-127434
4414-1674-1270763-170582
5518-2092-1585954-212730
6621-2511-19001144-255878
7725-2929-22151335-2971026
8829-3347-25301526-3391174
9932-3766-28451716-3821322
101036-4184-31601907-4241470

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%8.01.00.088.9%8.01.00.088.9%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%6.03.00.066.7%6.03.00.066.7%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%8.01.00.088.9%8.01.00.088.9%

Fundamentals of Lionco Pharm Grp Co Ltd

About Lionco Pharm Grp Co Ltd

Lionco Pharmaceutical Group Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in China. The company offers nutrition, antimicrobial, antiviral, digestion, cardiovascular, detoxification, anti-tumor, and other products. Lionco Pharmaceutical Group Co., Ltd. was founded in 2003 and is based in Shannan, China.

Fundamental data was last updated by Penke on 2024-04-18 13:32:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Lionco Pharm Grp Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Lionco Pharm Grp Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Lionco Pharm Grp Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -67.7% means that ¥-0.68 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Lionco Pharm Grp Co Ltd:

  • The MRQ is -67.7%. The company is making a huge loss. -2
  • The TTM is -67.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-67.7%TTM-67.7%0.0%
TTM-67.7%YOY8.9%-76.6%
TTM-67.7%5Y-3.9%-63.8%
5Y-3.9%10Y9.1%-13.0%
1.1.2. Return on Assets

Shows how efficient Lionco Pharm Grp Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Lionco Pharm Grp Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -10.5% Return on Assets means that Lionco Pharm Grp Co Ltd generated ¥-0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Lionco Pharm Grp Co Ltd:

  • The MRQ is -10.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.5%TTM-10.5%0.0%
TTM-10.5%YOY2.6%-13.2%
TTM-10.5%5Y3.5%-14.0%
5Y3.5%10Y8.5%-5.0%
1.1.3. Return on Equity

Shows how efficient Lionco Pharm Grp Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Lionco Pharm Grp Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -17.2% Return on Equity means Lionco Pharm Grp Co Ltd generated ¥-0.17 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Lionco Pharm Grp Co Ltd:

  • The MRQ is -17.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -17.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.2%TTM-17.2%0.0%
TTM-17.2%YOY4.5%-21.8%
TTM-17.2%5Y5.3%-22.6%
5Y5.3%10Y11.7%-6.4%

1.2. Operating Efficiency of Lionco Pharm Grp Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Lionco Pharm Grp Co Ltd is operating .

  • Measures how much profit Lionco Pharm Grp Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Lionco Pharm Grp Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -57.5% means the company generated ¥-0.57  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Lionco Pharm Grp Co Ltd:

  • The MRQ is -57.5%. The company is operating very inefficient. -2
  • The TTM is -57.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-57.5%TTM-57.5%0.0%
TTM-57.5%YOY8.7%-66.2%
TTM-57.5%5Y-4.0%-53.5%
5Y-4.0%10Y7.1%-11.1%
1.2.2. Operating Ratio

Measures how efficient Lionco Pharm Grp Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.89 means that the operating costs are ¥1.89 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Lionco Pharm Grp Co Ltd:

  • The MRQ is 1.889. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.889. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.889TTM1.8890.000
TTM1.889YOY1.112+0.777
TTM1.8895Y1.193+0.696
5Y1.19310Y1.074+0.119

1.3. Liquidity of Lionco Pharm Grp Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Lionco Pharm Grp Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.74 means the company has ¥3.74 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Lionco Pharm Grp Co Ltd:

  • The MRQ is 3.743. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.743. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.743TTM3.7430.000
TTM3.743YOY2.756+0.987
TTM3.7435Y2.995+0.748
5Y2.99510Y3.158-0.163
1.3.2. Quick Ratio

Measures if Lionco Pharm Grp Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Lionco Pharm Grp Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.59 means the company can pay off ¥1.59 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Lionco Pharm Grp Co Ltd:

  • The MRQ is 1.593. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.593. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.593TTM1.5930.000
TTM1.593YOY1.083+0.510
TTM1.5935Y1.129+0.464
5Y1.12910Y1.622-0.493

1.4. Solvency of Lionco Pharm Grp Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Lionco Pharm Grp Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Lionco Pharm Grp Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.39 means that Lionco Pharm Grp Co Ltd assets are financed with 38.8% credit (debt) and the remaining percentage (100% - 38.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Lionco Pharm Grp Co Ltd:

  • The MRQ is 0.388. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.388. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.388TTM0.3880.000
TTM0.388YOY0.420-0.032
TTM0.3885Y0.382+0.006
5Y0.38210Y0.306+0.076
1.4.2. Debt to Equity Ratio

Measures if Lionco Pharm Grp Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Lionco Pharm Grp Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 63.5% means that company has ¥0.63 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Lionco Pharm Grp Co Ltd:

  • The MRQ is 0.635. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.635. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.635TTM0.6350.000
TTM0.635YOY0.724-0.089
TTM0.6355Y0.630+0.004
5Y0.63010Y0.474+0.156

2. Market Valuation of Lionco Pharm Grp Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Lionco Pharm Grp Co Ltd generates.

  • Above 15 is considered overpriced but always compare Lionco Pharm Grp Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -21.15 means the investor is paying ¥-21.15 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Lionco Pharm Grp Co Ltd:

  • The EOD is -15.807. Based on the earnings, the company is expensive. -2
  • The MRQ is -21.149. Based on the earnings, the company is expensive. -2
  • The TTM is -21.149. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-15.807MRQ-21.149+5.343
MRQ-21.149TTM-21.1490.000
TTM-21.149YOY109.329-130.478
TTM-21.1495Y38.472-59.621
5Y38.47210Y65.546-27.074
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Lionco Pharm Grp Co Ltd:

  • The EOD is -28.336. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -37.913. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -37.913. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-28.336MRQ-37.913+9.577
MRQ-37.913TTM-37.9130.000
TTM-37.913YOY97.782-135.695
TTM-37.9135Y153.120-191.033
5Y153.12010Y225.611-72.491
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Lionco Pharm Grp Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Lionco Pharm Grp Co Ltd:

  • The EOD is 2.726. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.647. Based on the equity, the company is fair priced.
  • The TTM is 3.647. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.726MRQ3.647-0.921
MRQ3.647TTM3.6470.000
TTM3.647YOY4.939-1.292
TTM3.6475Y4.400-0.753
5Y4.40010Y8.222-3.822
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Lionco Pharm Grp Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.449-0.4490%-0.029-93%-0.046-90%0.175-357%
Book Value Per Share--1.5741.5740%2.023-22%1.876-16%1.653-5%
Current Ratio--3.7433.7430%2.756+36%2.995+25%3.158+19%
Debt To Asset Ratio--0.3880.3880%0.420-8%0.382+2%0.306+27%
Debt To Equity Ratio--0.6350.6350%0.724-12%0.630+1%0.474+34%
Dividend Per Share--0.1110.1110%0.221-50%0.205-46%0.171-35%
Eps---0.271-0.2710%0.091-397%0.115-336%0.159-271%
Free Cash Flow Per Share---0.151-0.1510%0.102-248%0.074-305%0.085-279%
Free Cash Flow To Equity Per Share---0.151-0.1510%-0.285+88%0.182-183%0.215-170%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---2.002--------
Intrinsic Value_10Y_min---5.605--------
Intrinsic Value_1Y_max--0.015--------
Intrinsic Value_1Y_min---0.133--------
Intrinsic Value_3Y_max---0.120--------
Intrinsic Value_3Y_min---0.773--------
Intrinsic Value_5Y_max---0.452--------
Intrinsic Value_5Y_min---1.818--------
Market Cap3094115207.040-34%4139911722.2404139911722.2400%7205177370.240-43%5999265802.368-31%10122981702.714-59%
Net Profit Margin---0.677-0.6770%0.089-860%-0.039-94%0.091-844%
Operating Margin---0.575-0.5750%0.087-757%-0.040-93%0.071-911%
Operating Ratio--1.8891.8890%1.112+70%1.193+58%1.074+76%
Pb Ratio2.726-34%3.6473.6470%4.939-26%4.400-17%8.222-56%
Pe Ratio-15.807+25%-21.149-21.1490%109.329-119%38.472-155%65.546-132%
Price Per Share4.290-34%5.7405.7400%9.990-43%8.318-31%14.036-59%
Price To Free Cash Flow Ratio-28.336+25%-37.913-37.9130%97.782-139%153.120-125%225.611-117%
Price To Total Gains Ratio-12.704+25%-16.998-16.9980%52.149-133%24.137-170%47.397-136%
Quick Ratio--1.5931.5930%1.083+47%1.129+41%1.622-2%
Return On Assets---0.105-0.1050%0.026-502%0.035-404%0.085-224%
Return On Equity---0.172-0.1720%0.045-482%0.053-423%0.117-247%
Total Gains Per Share---0.338-0.3380%0.192-276%0.159-312%0.345-198%
Usd Book Value--156649826.822156649826.8220%201318617.566-22%186731657.599-16%164496012.761-5%
Usd Book Value Change Per Share---0.062-0.0620%-0.004-93%-0.006-90%0.024-357%
Usd Book Value Per Share--0.2170.2170%0.279-22%0.259-16%0.228-5%
Usd Dividend Per Share--0.0150.0150%0.030-50%0.028-46%0.024-35%
Usd Eps---0.037-0.0370%0.013-397%0.016-336%0.022-271%
Usd Free Cash Flow---15068934.793-15068934.7930%10168729.518-248%7349062.092-305%8412158.685-279%
Usd Free Cash Flow Per Share---0.021-0.0210%0.014-248%0.010-305%0.012-279%
Usd Free Cash Flow To Equity Per Share---0.021-0.0210%-0.039+88%0.025-183%0.030-170%
Usd Market Cap426987898.572-34%571307817.669571307817.6690%994314477.093-43%827898680.727-31%1396971474.974-59%
Usd Price Per Share0.592-34%0.7920.7920%1.379-43%1.148-31%1.937-59%
Usd Profit---27013185.448-27013185.4480%9094693.525-397%11440889.558-336%15778120.666-271%
Usd Revenue--39918319.46039918319.4600%102165198.366-61%147246684.073-73%121833579.808-67%
Usd Total Gains Per Share---0.047-0.0470%0.026-276%0.022-312%0.048-198%
 EOD+3 -5MRQTTM+0 -0YOY+10 -255Y+6 -2910Y+5 -30

3.2. Fundamental Score

Let's check the fundamental score of Lionco Pharm Grp Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-15.807
Price to Book Ratio (EOD)Between0-12.726
Net Profit Margin (MRQ)Greater than0-0.677
Operating Margin (MRQ)Greater than0-0.575
Quick Ratio (MRQ)Greater than11.593
Current Ratio (MRQ)Greater than13.743
Debt to Asset Ratio (MRQ)Less than10.388
Debt to Equity Ratio (MRQ)Less than10.635
Return on Equity (MRQ)Greater than0.15-0.172
Return on Assets (MRQ)Greater than0.05-0.105
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Lionco Pharm Grp Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.068
Ma 20Greater thanMa 503.981
Ma 50Greater thanMa 1003.953
Ma 100Greater thanMa 2004.625
OpenGreater thanClose4.240
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Income before Tax  204,19018,734222,924-43,664179,260-108,78070,480-259,286-188,806
Net Income  182,70418,889201,592-41,520160,073-94,16965,904-261,651-195,748
EBIT  129,30348,588177,891-75,227102,664-37,92364,740-230,953-166,213
EBITDA  236,12135,937272,058-43,982228,076-98,988129,088-266,739-137,650
Operating Income  199,67916,712216,391-23,046193,345-123,71969,626-233,743-164,117
Net Income from Continuing Operations  182,70418,889201,592-41,520160,073-94,16965,904-261,651-195,748



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,855,465
Total Liabilities720,321
Total Stockholder Equity1,135,144
 As reported
Total Liabilities 720,321
Total Stockholder Equity+ 1,135,144
Total Assets = 1,855,465

Assets

Total Assets1,855,465
Total Current Assets1,132,043
Long-term Assets723,422
Total Current Assets
Cash And Cash Equivalents 575,763
Short-term Investments 389,515
Net Receivables 92,215
Inventory 49,138
Other Current Assets 13,557
Total Current Assets  (as reported)1,132,043
Total Current Assets  (calculated)1,120,188
+/- 11,855
Long-term Assets
Property Plant Equipment 496,324
Intangible Assets 115,791
Other Assets 33,509
Long-term Assets  (as reported)723,422
Long-term Assets  (calculated)645,623
+/- 77,799

Liabilities & Shareholders' Equity

Total Current Liabilities302,423
Long-term Liabilities417,898
Total Stockholder Equity1,135,144
Total Current Liabilities
Short Long Term Debt 205,243
Accounts payable 66,455
Other Current Liabilities 21,021
Total Current Liabilities  (as reported)302,423
Total Current Liabilities  (calculated)292,719
+/- 9,704
Long-term Liabilities
Long term Debt 412,523
Capital Lease Obligations Min Short Term Debt1,066
Other Liabilities 4,309
Deferred Long Term Liability 20,096
Long-term Liabilities  (as reported)417,898
Long-term Liabilities  (calculated)437,994
+/- 20,096
Total Stockholder Equity
Common Stock721,238
Retained Earnings 120,441
Other Stockholders Equity 94,092
Total Stockholder Equity (as reported)1,135,144
Total Stockholder Equity (calculated)935,771
+/- 199,373
Other
Capital Stock721,238
Common Stock Shares Outstanding 721,238
Net Debt 42,003
Net Invested Capital 1,752,910
Net Working Capital 829,620
Property Plant and Equipment Gross 496,324



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
> Total Assets 
559,834
1,343,507
1,344,015
1,651,653
2,067,927
1,913,436
2,716,209
2,514,364
1,855,465
1,855,4652,514,3642,716,2091,913,4362,067,9271,651,6531,344,0151,343,507559,834
   > Total Current Assets 
0
944,378
893,098
1,132,152
1,326,462
1,226,063
2,038,816
1,788,287
1,132,043
1,132,0431,788,2872,038,8161,226,0631,326,4621,132,152893,098944,3780
       Cash And Cash Equivalents 
81,607
158,664
220,059
312,813
711,445
510,986
1,566,976
986,937
575,763
575,763986,9371,566,976510,986711,445312,813220,059158,66481,607
       Short-term Investments 
0
600,000
500,000
500,000
325,000
355,776
180,000
579,125
389,515
389,515579,125180,000355,776325,000500,000500,000600,0000
       Net Receivables 
9,808
76,610
74,240
198,627
180,221
240,712
171,408
123,520
92,215
92,215123,520171,408240,712180,221198,62774,24076,6109,808
       Other Current Assets 
13,858
22,340
18,386
29,171
37,124
28,783
40,872
37,951
13,557
13,55737,95140,87228,78337,12429,17118,38622,34013,858
   > Long-term Assets 
0
0
450,918
519,501
741,465
687,372
677,392
726,077
723,422
723,422726,077677,392687,372741,465519,501450,91800
       Property Plant Equipment 
306,123
329,765
333,058
405,402
490,822
490,518
465,468
484,532
496,324
496,324484,532465,468490,518490,822405,402333,058329,765306,123
       Goodwill 
2,030
2,030
2,030
2,030
2,030
2,030
2,030
2,030
0
02,0302,0302,0302,0302,0302,0302,0302,030
       Long Term Investments 
0
0
0
0
92,225
0
0
0
0
000092,2250000
       Intangible Assets 
49,047
46,153
45,450
44,410
47,522
50,498
102,698
124,097
115,791
115,791124,097102,69850,49847,52244,41045,45046,15349,047
       Long-term Assets Other 
0
0
46,470
46,000
89,052
44,933
8,483
8,366
6,217
6,2178,3668,48344,93389,05246,00046,47000
> Total Liabilities 
185,703
223,982
174,566
352,398
689,968
599,604
1,236,334
1,055,533
720,321
720,3211,055,5331,236,334599,604689,968352,398174,566223,982185,703
   > Total Current Liabilities 
167,791
207,090
160,732
340,055
504,372
400,705
731,573
648,849
302,423
302,423648,849731,573400,705504,372340,055160,732207,090167,791
       Short-term Debt 
0
0
0
0
200,000
60,043
0
0
0
00060,043200,0000000
       Short Long Term Debt 
0
0
0
0
200,000
60,043
389,746
460,291
205,243
205,243460,291389,74660,043200,0000000
       Accounts payable 
126,709
94,398
87,536
98,904
105,415
109,023
39,023
62,102
66,455
66,45562,10239,023109,023105,41598,90487,53694,398126,709
       Other Current Liabilities 
41,082
36,322
41,763
60,753
70,454
57,046
237,408
26,808
21,021
21,02126,808237,40857,04670,45460,75341,76336,32241,082
   > Long-term Liabilities 
0
0
13,833
12,343
185,595
198,900
504,760
406,684
417,898
417,898406,684504,760198,900185,59512,34313,83300
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
-200,000
-60,043
17,877
14,771
1,066
1,06614,77117,877-60,043-200,0000000
       Long-term Liabilities Other 
0
0
0
0
175,000
190,000
0
0
0
000190,000175,0000000
       Deferred Long Term Liability 
0
12,638
21,318
18,637
17,376
14,566
26,501
23,917
20,096
20,09623,91726,50114,56617,37618,63721,31812,6380
> Total Stockholder Equity
374,131
1,119,525
1,169,450
1,299,255
1,377,959
1,313,832
1,479,875
1,458,831
1,135,144
1,135,1441,458,8311,479,8751,313,8321,377,9591,299,2551,169,4501,119,525374,131
   Common Stock
195,000
260,000
260,000
260,000
364,000
509,600
713,440
721,227
721,238
721,238721,227713,440509,600364,000260,000260,000260,000195,000
   Retained Earnings 
169,829
212,274
262,199
392,004
470,708
406,580
464,733
387,949
120,441
120,441387,949464,733406,580470,708392,004262,199212,274169,829
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 
0
0
0
0
0
0
107,890
94,111
94,092
94,09294,111107,890000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue188,720
Cost of Revenue-113,705
Gross Profit75,01675,016
 
Operating Income (+$)
Gross Profit75,016
Operating Expense-354,891
Operating Income-166,170-279,875
 
Operating Expense (+$)
Research Development34,993
Selling General Administrative160,394
Selling And Marketing Expenses-
Operating Expense354,891195,387
 
Net Interest Income (+$)
Interest Income10,395
Interest Expense-2,763
Other Finance Cost-6,716
Net Interest Income916
 
Pretax Income (+$)
Operating Income-166,170
Net Interest Income916
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-216,821-166,170
EBIT - interestExpense = -2,763
-222,857
-220,094
Interest Expense2,763
Earnings Before Interest and Taxes (EBIT)--214,057
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-216,821
Tax Provision-6,036
Net Income From Continuing Ops-222,857-222,857
Net Income-222,857
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--916
 

Technical Analysis of Lionco Pharm Grp Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Lionco Pharm Grp Co Ltd. The general trend of Lionco Pharm Grp Co Ltd is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Lionco Pharm Grp Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Lionco Pharm Grp Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.4 < 4.45 < 4.52.

The bearish price targets are: 4.17 > 3.37 > 2.94.

Tweet this
Lionco Pharm Grp Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Lionco Pharm Grp Co Ltd. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Lionco Pharm Grp Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Lionco Pharm Grp Co Ltd. The current macd is 0.0233536.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Lionco Pharm Grp Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Lionco Pharm Grp Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Lionco Pharm Grp Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Lionco Pharm Grp Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartLionco Pharm Grp Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Lionco Pharm Grp Co Ltd. The current adx is 15.84.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Lionco Pharm Grp Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Lionco Pharm Grp Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Lionco Pharm Grp Co Ltd. The current sar is 3.60068164.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Lionco Pharm Grp Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Lionco Pharm Grp Co Ltd. The current rsi is 60.07. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
Lionco Pharm Grp Co Ltd Daily Relative Strength Index (RSI) ChartLionco Pharm Grp Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Lionco Pharm Grp Co Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Lionco Pharm Grp Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Lionco Pharm Grp Co Ltd Daily Stochastic Oscillator ChartLionco Pharm Grp Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Lionco Pharm Grp Co Ltd. The current cci is 150.69.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Lionco Pharm Grp Co Ltd Daily Commodity Channel Index (CCI) ChartLionco Pharm Grp Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Lionco Pharm Grp Co Ltd. The current cmo is 34.84.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Lionco Pharm Grp Co Ltd Daily Chande Momentum Oscillator (CMO) ChartLionco Pharm Grp Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Lionco Pharm Grp Co Ltd. The current willr is -11.53846154.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Lionco Pharm Grp Co Ltd Daily Williams %R ChartLionco Pharm Grp Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Lionco Pharm Grp Co Ltd.

Lionco Pharm Grp Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Lionco Pharm Grp Co Ltd. The current atr is 0.18569616.

Lionco Pharm Grp Co Ltd Daily Average True Range (ATR) ChartLionco Pharm Grp Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Lionco Pharm Grp Co Ltd. The current obv is 96,951,334.

Lionco Pharm Grp Co Ltd Daily On-Balance Volume (OBV) ChartLionco Pharm Grp Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Lionco Pharm Grp Co Ltd. The current mfi is 68.53.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Lionco Pharm Grp Co Ltd Daily Money Flow Index (MFI) ChartLionco Pharm Grp Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Lionco Pharm Grp Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-28ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Lionco Pharm Grp Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Lionco Pharm Grp Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.068
Ma 20Greater thanMa 503.981
Ma 50Greater thanMa 1003.953
Ma 100Greater thanMa 2004.625
OpenGreater thanClose4.240
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Lionco Pharm Grp Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Lionco Pharm Grp Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Lionco Pharm Grp Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Lionco Pharm Grp Co Ltd

I send you an email if I find something interesting about Lionco Pharm Grp Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Lionco Pharm Grp Co Ltd.

Receive notifications about Lionco Pharm Grp Co Ltd in your mailbox!